Status:

UNKNOWN

Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

Lead Sponsor:

Nevada Cancer Institute

Collaborating Sponsors:

Vons

Conditions:

Early Stage Breast Cancer (Stage 0-III)

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

The proposed study compares the outcomes of a physical activity intervention begun at diagnosis, continuing through active cancer treatment and into six months of survivorship compared to the outcomes...

Detailed Description

Patients (with stage 0 to stage III breast cancer)receiving chemotherapy, radiation or both chemotherapy and radiation will be included in the study.Randomization will be stratified by disease stage a...

Eligibility Criteria

Inclusion

  • Consent to participate in study
  • Women aged 18 and older
  • Stage 0 to III breast cancer prior to any treatment and at time of diagnosis
  • Requires treatment that includes chemotherapy, radiation therapy or both chemotherapy and radiation therapy
  • Adequate fitness to participate in a physical activity as assessed by the investigator
  • Willing and able to participate in a prescribed exercise program

Exclusion

  • Metastatic breast cancer (Stage IV)
  • Initiation of treatment regimen prior to enrollment
  • Treatment for breast cancer not requiring chemotherapy or radiation therapy
  • Patients who are pregnant (negative urine pregnancy test required at baseline to determine eligibility in women of child bearing potential).
  • Currently lactating
  • Do not read, understand, or speak English
  • Eligible participants will not be included if they have:
  • known cardiac disease,
  • uncontrolled hypertension,
  • uncontrolled thyroid disease,
  • diabetes mellitus,
  • mental illness,
  • infection,
  • immune or endocrine abnormality,
  • body weight reduction I10% in past 6 months, and
  • positive exercise stress test.
  • Major surgery within last 6 months that requires exercise restriction

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT01157130

Start Date

July 1 2010

Last Update

July 20 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Nevada Cancer Institute

Las Vegas, Nevada, United States, 89135